Galectin Therapeutics Inc (GALT)

0.8115 -0.08 (-8.83%) USD  |  NASDAQ  |  Dec 24, 12:37
More

Galectin Therapeutics Cash and Short Term Investments (Quarterly): 27.06M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Alaunos Therapeutics Inc 1.683M
SELLAS Life Sciences Group Inc 21.03M
Oragenics Inc 3.144M
Anavex Life Sciences Corp 138.76M
Phathom Pharmaceuticals Inc 334.68M